PATENT CLAIM ANALYSIS

Application Number: 16061137
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "417000"]

Abstract:
Described herein is the formulation of immunogenic or vaccine compositions comprising neutral lipid liposome based adjuvants, where the composition is suitable for lyophilisation. In particular, the invention relates to lyophilised forms of such immunogenic or vaccine compositions wherein both the immunogen or vaccine antigen and the adjuvant are present in one and the same vial, as well as to the formulation and manufacture of lyophilised forms of such immunogenic or vaccine composition.

Claim (Index 10):
A composition according to  claim 1 , further comprising an antigen.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.67391
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16466094', '15300338', '12946171', '13020045', '15354233']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6650218901621243
- 35 USC 102 Novelty (BERT): 0.4942674970954341
- Combined Prediction Score: 0.6479464508554553
- Mean Citation Score: 178.70615200000003
- Max Citation Score: 193.93002
- Similarity Product: 134.6007511073828

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test